![James Tyree](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Tyree
Direktor/Vorstandsmitglied bei
GENELUX CORPORATION
Vermögen: 207 626 $ am 31.05.2026
Profil
James L.
Tyree is the founder of Tyree & D’Angelo Partners Management LP, founded in 2013, where the title held is Chairman & Managing Partner.
Current jobs include Lead Independent Director at Genelux Corp.
since 2021 and Member at The Chicago Council on Global Affairs.
Former jobs include Independent Director at Assertio Therapeutics, Inc., Independent Director at ChemoCentryx, Inc. from 2012 to 2022, Independent Director at SonarMed, Inc., Independent Director at Innoviva, Inc. from 2014 to 2017, Director at TAP Pharmaceutical Products, Inc., Independent Director at Assertio Holdings, Inc. from 2016 to 2024, Executive Vice President-Pharmaceutical Products at Abbott Laboratories from 1997 to 2009, Principal at Bristol Myers Squibb Co., Principal at Pfizer Inc., President at Sugen, Inc., Executive Vice President at Global Pharmaceuticals Cos LLC, Principal at Abbott Biotech Ventures, Inc., and Senior Vice President at Global Nutritionals, Inc. Education includes undergraduate studies at Indiana University and an MBA from Kelley School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENELUX CORP. 0,15 % | 16.03.2026 | 68.074 ( 0,15 % ) | 207 626 $ | 31.05.2026 |
Aktive Positionen von James Tyree
| Unternehmen | Position | Beginn |
|---|---|---|
| GENELUX CORPORATION | Direktor/Vorstandsmitglied | 01.07.2021 |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Gründer | 01.01.2013 |
The Chicago Council on Global Affairs
 The Chicago Council on Global Affairs Miscellaneous Commercial ServicesCommercial Services Operates as independent nonpartisan membership organization that provides insight and influence the public disclosure on critical global issues | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Tyree
| Unternehmen | Position | Ende |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Direktor/Vorstandsmitglied | 23.05.2024 |
| CHEMOCENTRYX, INC. | Direktor/Vorstandsmitglied | 20.10.2022 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.08.2009 |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Präsident | - |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ausbildung von James Tyree
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
SonarMed, Inc.
 SonarMed, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and manufactures airway monitoring systems | Electronic Technology |
Global Pharmaceuticals Cos LLC
 Global Pharmaceuticals Cos LLC Miscellaneous Commercial ServicesCommercial Services Researches and develops medical products and equipment for the urine collection and testing market | Commercial Services |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Health Technology |
The Chicago Council on Global Affairs
The Chicago Council on Global Affairs Miscellaneous Commercial ServicesCommercial Services Operates as independent nonpartisan membership organization that provides insight and influence the public disclosure on critical global issues | Commercial Services |
Abbott Biotech Ventures, Inc.
 Abbott Biotech Ventures, Inc. Investment ManagersFinance Abbott Biotech Ventures invests in companies located in the United States. The firm focuses on sectors such as biotech and pharmaceutical sectors such as neuroscience, immunology, cardiology, virology, and oncology. It participates in early-stage transactions. | Finance |
Global Nutritionals, Inc. | |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyree & D’Angelo Partners Management LP
Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Finance |
Assertio Holdings, Inc.
 Assertio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
